Department of Drug Administration Drug Recall Notice
DDA Publish Urgent Notice Regarding Drug Recall.
During the market monitoring, the samples collected from this Department of Drug Administration – DDA were tested and found to be of poor quality.This information has been published for the information of the concerned industry to stop the sale and distribution of the drug in accordance with Section 14 of the Drugs Act 2035 and to recall it from the market immediately and submit its details to the Department of Drug Administration – DDA. Also, all concerned are requested not to recommend, sell, distribute and even use the drug.
Recall Drug List:
- Gastogel Suspension
- Lipilage 10
- Irgonol – 200
- Syntran – 200
- DDA Notice Regarding False and Misleading Propaganda of Medicines
- DDA has given Emergency use Authorization of Vero Cell vaccine in Nepal
- DDA Approved COVISHIELD COVID-19 Vaccine for Emergency Use Authorization in Nepal
- DDA Notice Regarding Registration Permission for Emergency use of Covid-19 Vaccine